Cliprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H11ClO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BB27ZR25WO, chemically known as benzeneacetic acid, 3-chloro-alpha-methyl-4-(2-thienylcarbonyl)- but generally known as cliprofen, which bears US NIH Compound Identifier 167449. European Medicines Agency schedules Cliprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06671MIG. The term CLIPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). CLIPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cliprofen under HS 29349990 and SITC 51579. As of Q4 2014, CLIPROFEN remains the US FDA Preferred Term for this commodity. Cliprofen bears US NLM identifiers UMLS ID C2699354 and NCI Concept Code C77343. SMILES: CLC1CC(C(C)C(=O)O)CCC1C(=O)C1SCCC1.